Engineering Dendritic Cells to Treat Cancer
A conversation with Ananya Zutshi, MS/MBA (CEO) and Ricky Barrett, PhD (CSO), co-founders of Guardian Bio.
This is Signal. The new voice for next generation biotech leaders, presented by Nucleate.
Get the email newsletter and unlock access to members-only content and updates
Processing your application
Please check your inbox and click the link to confirm your subscription.
There was an error sending the email
Get started with our best stories
NYC Founder’s Spotlight: Climate-Saving Microbes
The New York biotech scene is growing more each year, and it can be hard to keep up with the newest companies and the latest innovations. In an effort to learn more about what the NYC biotech ecosystem has to offer, we aimed to interview biotech CEOs around the city...
Biotech Venture Capital Activity in Brazil
Brazilian VC funding in biotech is on the rise, with approximately 50 firms investing in a diverse range of biotech sectors.
Enter the World of Hidden Layers
Introduction to the Nucleate Biotech Ecosystem Insights Series.
Robotics Will Liberate Biotech Creativity
A conversation with Martin Immanuel-Bittner, co-founder and CEO of Arctoris.
The Beginning of the Microbe Metaverse
A conversation with Cheri Ackerman, co-founder and CEO of Concerto Biosciences.
Nature is the Master Multitasker
A conversation with Gleb Kuznetsov, founder of Manifold Bio.
Introducing Signal
The human story of biotechnology, and how it will change life as we know it.
Engineering Dendritic Cells to Treat Cancer
A conversation with Ananya Zutshi, MS/MBA (CEO) and Ricky Barrett, PhD (CSO), co-founders of Guardian Bio.
NYC Founder’s Spotlight: Climate-Saving Microbes
The New York biotech scene is growing more each year, and it can be hard to keep up with the newest companies and the latest innovations. In an effort to learn more about what the NYC biotech ecosystem has to offer, we aimed to interview biotech CEOs around the city...
Biotech Venture Capital Activity in Brazil
Brazilian VC funding in biotech is on the rise, with approximately 50 firms investing in a diverse range of biotech sectors.
Enter the World of Hidden Layers
Introduction to the Nucleate Biotech Ecosystem Insights Series.
Generative AI will rapidly accelerate drug development
A conversation with Sean McClain, co-founder and CEO and co-founder of Absci.
Pioneering Cell Therapy
A conversation with Professor Bobby Gaspar, the CEO of Orchard Therapeutics.
